ONO-4915

N/A

Report date: 2026/03/23 20:03:44

Base Information

Drug NameONO-4915

Drug Alias NameONO-4915

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionProgrammed cell death protein 1 blockersAnti-CD19

TargetsProgrammed cell death protein 1B-lymphocyte antigen CD19

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesOno Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesOno Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A